U.S. COVID-19 Vaccine Supply Chain Suppliers Facilities: Moderna

Identified United States COVID-19 Vaccine manufacturing facilities and suppliers

Source: Griffin, R. Bloomberg’s News Article, Jan. 26, 2021, “Pfizer to Deliver U.S. Vaccine Doses Faster Than Expected”, Retrieved, Jan. 30th, 2021. Higgings, N., CNBC’s News Article, Jan. 4th, 2021, “Moderna increases minimum 2021 Covid vaccine production by 20% to 600 million doses”, Retrieved, Jan. 30th, 2021. Sullivan, P.,The Hill, News Article, Jan. 4th, 2021, “Johnson & Johnson on track for 100 million vaccine doses by end of June, bolstering US supply”, Retrieved, Jan. 31st, 2021. Moderna Press Release, Jan. 27th 2021, Moderna confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine, Retrieved, Feb. 1st, 2021. USITC (2020). COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges. Dec. 2020. U.S. Census Population Estimates 2019, Retrieved – Jan. 29th 2021. Pfizer, Press Release, Dec. 23, 2020, “Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine”, Retrieved, Jan. 31st, 2021. Pfizer, Press Release, Dec. 23, 2020, “Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine”, Retrieved, Jan. 31st, 2021. U.S. Department of Health & Human Services – Operation Warp Speed Logistics - 12/03/2020. Karen Young, Omar Chane, Glenn Hunzinger, and Benjamin Isgur. Sept. 2020, "Developing COVID-19 vaccines may not be enough: Turning vaccines into vaccinations." PwC Health Research Institute. Endo International, “Endo Announces Fill-Finish Manufacturing,” September 25, 2020; Emergent BioSolutions, “Emergent BioSolutions Signs Agreement,” April 23, 2020; Emergent BioSolutions, “Emergent BioSolutions Signs Agreement,” July 27, 2020; Emergent BioSolutions, “Emergent BioSolutions Signs Five-Year Agreement,” July 6, 2020; Catalent, “Moderna and Catalent Announce Collaboration,” June 25, 2020; Catalent, “Catalent Signs Agreement,” August 24, 2020; Inovio, “INOVIO Adds Thermo Fisher Scientific,” September 8, 2020; Novavax, “Novavax Announces Facility Expansion,” November 2, 2020; Blankenship, “Emergent BioSolutions, BARDA Reach,” June 1, 2020; Novavax, “Novavax and FUJIFILM Diosynth,” July 23, 2020; Platoff, “Texas Biotech Facility,” July 27, 2020; Keown, “Federal Government Taps,” July 28, 2020; BioSpace, “Vaxart Announces,” March 18, 2020; Grand River Aseptic Manufacturing, “GRAM Partners,” September 25, 2020; Mullin, “Moderna Picks,” May 1, 2020; Stanton, “Inhouse Manufacturing,” May 19, 2020; Avid Bioservices, “Oragenics Signs Process Development,” August 20, 2020; Catalent, “Arcturus Therapeutics and Catalent,” May 4, 2020; Catalent, “Catalent Signs Agreement,” April 29, 2020; Veleta, “Potential Covid Vaccine,” May 28, 2020; Pfizer, “Scaling Up to Manufacture,” May 5, 2020; Contract Pharma, “Kindred, Vaxart Enter COVID- 19,” May 22, 2020; Ology Bioservices, “U.S. Army Contracting Command,” August 26, 2020; AGC, “AGC Expands Contract,” August 18, 2020; Intelligencer, “Sanofi: COVID-19 Vaccines,” August 4, 2020; GlaxoSmithKline, “GSK Announces Intention,” May 28, 2020; GRAM Website, “Large Scale Filling” (accessed November 15, 2020); Martin, “Inside the Operation Warp Speed Effort,” November 8, 2020; Feingold, “When Vaccine is Ready,” October 2, 2020; Johnson, “A vial, a Vaccine and Hopes,” November 17, 2020; Altimmune, “Altimmune Announces Manufacturing Agreement,” July 22, 2020; Vigene Biosciences, “Vigene Biosciences Secures Institutional,” April 29, 2019; NantKwest, “ImmunityBio & NantKwest Sign,” May 27, 2020; NantKwest, “Form 10-K, March 25, 2020, 8, 114; Medicago, “Medicago Begins Phase I,” July 14, 2020; Medicago Website, “Frequently Asked Questions” (accessed November 18, 2020); CordenPharma, “Core Capabilities” (accessed November 17, 2020); CordenPharma, “Moderna Extends Lipid Supply,” May 28, 2020.; Centaur Biopharmaceutical Services, “cGMP Manufacturing” (accessed November 18, 2020); KindredBiosciences, “Kindred Biosciences Announces Expansion,” October 7, 2020; Catalant, “Catalent Partners with Spincona,” June 10, 2020; Rodriguez, “Novavax COVID-19 Vaccine Receives,” November 10, 2020; Businesswire, “Moderna and Catalent Announce”, June 25, 2020; Stanton, “Inovio’s COVID-19 vaccine,” April 8, 2020; Blakenship, “Inovio Accuses Manfacturing Partner,” June 5, 2020; Sagonowsky, “Moderna has started turning out COVID-19 ,” July 15, 2020; Gilgore, “Novavax’s latest win?,” June 5, 2020; Hargreaves, “Altimmune Partners with Lonza,” BioProcess International, November 16, 2020; Catalent. “Catalent Biologics Invests $50 Million,” September 2, 2020; Keller and Krabbe, “ABQ Plant to Play a Role,” September 18, 2020.